$13.07 0.28 (+2.19%)
12/4/2009 9:56 AM

Cepheid (CPHD)

CAPS Rating: 4 out of 5

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Featured Broker Partners